THERAPEUTIC
PHARMACEUTICALS,
a manufacturing unit of Quality Formulations, was
established in 1961 by Mr.
K.P.Menon.
Over the years Therapeutic has established a reputation
for innovative work and the Quality of its products. The
firm presently has its Pharmaceutical formulations unit
in Central Mumbai (Prabhadevi) and has departments to
manufacture Tablets,
Capsules, Liquids
&
Injections. The facility has an in-house Quality Control
Laboratory. All these departments are manned by
highly trained FDA approved personnel.
In the
early years the firm carried out Research & Development
work both in- house & jointly with several
Universities/Hospitals all over India, and as a result,
was able to introduce several new formulations to the
Medical profession. One of these products is Paracetamol
solubilized in Injectable form & Pediatric
Drop
form branded as
AEKNIL.
Prior to
launching this product, the firm conducted extensive
clinical trials and the findings were documented in
various Medical journals.
While
AEKNIL
is the most recognized product of the Company, the other
“First Time” products introduced were items like SOLUCORT
(Prednisolone solubilized for the first time in
palatable pediatric drop form), GLUCOCORT
(Dexamethazone solubilized), Isoniazid-PAS combination etc.
The firm
has been marketing its formulations ethically all over
India through its Authorized agents, participating in
Government Tenders and has been supplying to Premier
Institutions like the
Indian
Railway Hospitals,
BHEL,
ISRO,
TELCO
etc. The firm has been exporting its formulations since
mid nineteen sixties and its products are registered
with the Ministry of Health in various countries.
The firm
has a Good
Manufacturing Practice (GMP) certificate
from the Food & Drug
Administration- Maharashtra, India, who is the Governing
& Regulating Body of the organization.
The implementation of the
new Schedule M norms as stipulated by the Drug
Controller of India will further improve the Quality of
the Formulations manufactured and help to exploit the
export potential of the Company. Also, the adoption of
other Quality Standards, such as ISO 9000 will allow the
Company to expand and introduce its product range to new
Markets, both within India and countries abroad. This
could also help promote a business alliance of
Therapeutic along with suitable larger companies, which
would prove mutually beneficial.
|